Malin Corporation

H1 2019 results: value/price disconnect compelling

  • Sectors : Pharma and healthcare
  • Companies : Malin Corporation

Ratings and price correct at time of issue.

  • Malin Corporation

    Closing Price: 242c

  • RATING 29/09/15



The modest 5% reduction in Malin’s IPEV stands in stark contrast to its 52% share price decline year-to-date. The latter is largely driven by overhang concerns due to Woodford IM’s 23% stake. With several significant valuation milestones approaching in 2019 and 2020, and the scope for capital returns, Malin’s share price discount of almost 70% to its IPEV-derived fair value per share of €7.9 provides a compelling opportunity for investors to generate outsized returns over the next 18 months.

Download full report with analyst certification and important disclosures

Sep 3 2019, 07:10 IST/BST